What does a CD4‑cell count of 5 cells/µL and a positive cryptococcal antigen test indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Severe AIDS-Defining Immunosuppression with Active or Impending Cryptococcal Disease

A CD4 count of 5 cells/µL with positive cryptococcal antigen indicates severe AIDS-defining immunosuppression with either active cryptococcal infection or imminent risk of cryptococcal meningitis, requiring urgent diagnostic lumbar puncture and immediate antifungal therapy. 1

Immediate Clinical Significance

This combination represents a medical emergency with extremely high mortality risk:

  • Cryptococcal antigenemia at CD4 <100 cells/µL predicts 2-3 times higher mortality compared to CrAg-negative patients, with death rates of 22-75% within one year even with treatment 2, 3, 4
  • At CD4 count of 5 cells/µL, the patient has virtually no functional cellular immunity and is at maximum risk for disseminated opportunistic infections 1
  • Positive CrAg preceded symptomatic meningitis by a median of 22 days in prospective studies, meaning this patient may already have or will soon develop meningitis 1

Urgent Diagnostic Algorithm

Step 1: Immediate Lumbar Puncture (Do Not Delay)

Perform lumbar puncture immediately regardless of symptoms to determine if cryptococcal meningitis is already present: 1

  • Send CSF for cryptococcal antigen, India ink stain, fungal culture, opening pressure
  • 33% of patients with positive serum CrAg have asymptomatic meningitis at time of screening 5
  • Opening pressure measurement is critical as elevated intracranial pressure is the primary cause of death 1

Step 2: Interpret Results and Initiate Treatment

If CSF is CrAg-positive or culture-positive (cryptococcal meningitis):

  • Start liposomal amphotericin B (3-4 mg/kg/day IV) plus flucytosine (100 mg/kg/day in 4 divided doses) for induction therapy for at least 2 weeks 1
  • Manage elevated intracranial pressure aggressively with serial therapeutic lumbar punctures to maintain opening pressure <20 cm H₂O 1
  • Do NOT start antiretroviral therapy immediately—delay ART for 4-6 weeks after starting antifungal therapy to reduce risk of IRIS 1

If CSF is CrAg-negative (asymptomatic cryptococcal antigenemia):

  • Start high-dose fluconazole 800 mg daily as preemptive therapy [5, @19@]
  • This reduces progression to meningitis from 21.4% to 5.7% 5
  • Consider repeating lumbar puncture if symptoms develop or CrAg titer is very high (>1:160) 4

Additional Critical Considerations at CD4 Count of 5 cells/µL

Prophylaxis for Other Opportunistic Infections

This patient requires immediate prophylaxis for multiple opportunistic infections: 1

  • Pneumocystis jirovecii pneumonia (PCP): Start trimethoprim-sulfamethoxazole double-strength daily (CD4 <200 threshold far exceeded) 1
  • Toxoplasma gondii: Same TMP-SMX regimen provides dual prophylaxis 1
  • Mycobacterium avium complex (MAC): Start azithromycin 1200 mg weekly (CD4 <50 threshold exceeded) 1

Screening for Other Endemic Fungi

At CD4 <150 cells/µL, consider screening for: 1

  • Histoplasmosis if patient resides in or has traveled to Ohio/Mississippi River Valleys or Latin America
  • Disseminated histoplasmosis occurs almost exclusively at CD4 <150 cells/µL 1

Prognosis and Monitoring

  • Even with optimal treatment, mortality remains 2.2 times higher in CrAg-positive versus CrAg-negative patients 5
  • Monitor for immune reconstitution inflammatory syndrome (IRIS) when ART is eventually started 1
  • Continue fluconazole maintenance therapy (200 mg daily) after completing induction/consolidation until CD4 >200 cells/µL for >6 months on ART 1

Common Pitfalls to Avoid

  • Never delay lumbar puncture in CrAg-positive patients—asymptomatic meningitis is present in one-third of cases and requires different treatment 5
  • Never start ART immediately in patients with active cryptococcal disease—this increases IRIS risk and mortality 1
  • Never use fluconazole monotherapy if meningitis is confirmed—amphotericin B plus flucytosine is required for induction 1
  • Never ignore elevated intracranial pressure—this is the primary cause of death and requires aggressive serial lumbar punctures 1
  • Never assume the patient only has cryptococcosis—at CD4 of 5 cells/µL, multiple concurrent opportunistic infections are common 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015

Guideline

Differential Diagnosis of Low CD4 Count

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.